ELVN Enliven Therapeutics, Inc.
$43.69▲ +5.30%
Healthcare
Other
After hours
$43.69▲ +0.00%
Oct 27, 4:00 PM ET
Volume 3.31M
Avg Volume (10D) 1.76M
Key Metrics & Fundamentals
Market Cap
$3.20B
P/E Ratio
–
Div Yield
0.00%
52W Range
14.79 - 62.32
% vs 50 MA
-11.89%
% vs 200 MA
2.93%
RSI-14
49.5
MACD Histogram
+0.8000
Beta (1Y vs SPY)
1.01
Free Cash Flow
-$18.63M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$37.20M
COGS
–
Operating Exp
$37.21M
Operating Income
-$37.21M
EBIT
-$37.21M
Pretax Income
-$32.49M
Net Income
-$32.49M
EPS (Diluted)
-0.49
Price & Volume History
Loading chart…
Recent News
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
PR Newswire · Oct 14, 2026 4:30 PM ET
Why Enliven Therapeutics' (ELVN) ENABLE-2 Trial Design Raises New Questions About Its CML Strategy
Simply Wall St. · Oct 10, 2026 12:20 AM ET
Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial
BioPharma Dive · Oct 7, 2026 11:21 AM ET
Enliven Therapeutics Reaches Realignment With FDA on Final Design of Relcobatinib's Phase 3 Trial
MT Newswires · Oct 7, 2026 5:01 AM ET
Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia
PR Newswire · Oct 6, 2026 4:05 PM ET
Morgan Stanley Initiates Enliven Therapeutics at Overweight
MT Newswires · Oct 2, 2026 6:49 AM ET
JPMorgan Initiates Enliven Therapeutics at Overweight With $75 Price Target
MT Newswires · Oct 1, 2026 5:45 AM ET
Enliven Therapeutics Insider Sold Shares Worth $251,754, According to a Recent SEC Filing
MT Newswires · Sep 21, 2026 5:30 PM ET
Enliven Therapeutics Insider Sold Shares Worth $303,003, According to a Recent SEC Filing
MT Newswires · Sep 21, 2026 5:27 PM ET
Enliven Therapeutics to Present at Upcoming Investor Conferences
PR Newswire · Sep 3, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ELVN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.